About
The Models to Medicine Center harnesses campus research strengths in life sciences to foster translational applications, create synergistic ties with industry, and improve the training of future life scientists, especially those who will join the workforce in the commonwealth.
Established in 2013, the center advances translational research at UMass and supports life sciences driven economic development. The Models to Medicine Center is one of three centers supported with more than $150 million in capital investments to date by the Massachusetts Life Sciences Center and UMass Amherst as part of the university’s new Institute for Applied Life Sciences (IALS).
M2M Leadership
- Peter Chien, Biochemistry & Molecular Biology, Director
- Jeanne Hardy, Chemistry, Associate Director
- Shelley Peyton, Chemical Engineering, Associate Director
M2M Steering Committee/Theme Leaders
- Peter Chien, Biochemistry & Molecular Biology
- Jeanne Hardy, Chemistry
- Sam Hazen, Plant and Microbial Innovation
- Mike Henson, Microbiome, Microbes & Infectious Diseases
- D. Joseph Jerry, Engineered Models and Mechanisms in Cancer (EM²C)
- David Moorman, Mechanisms of Neural Function & Dysfunction
- Barbara Osborne, Veterinary and Animal Sciences
- Shelly Peyton, Chemical Engineering
- Leonid Pobezinsky, Infection & Immunity
- Peter Reinhart, IALS
- Maria Santore, Membranes in Biology & Medicine
- Celia Schiffer, UMMS
- Jessica Schiffman, Biomaterials for Devices and Regenerative Medicine (BDRM)
- Ned Debold, mUscleMASS
- Dan Hebert, Protein Homeostasis
- Pablo Visconti, Contraception, Reproduction Assistance Technologies and Embryology (CReATE)
- Pat Wadsworth, Cellular Dynamics
M2M All-Hands Meetings
- February 9, 2018 - Presentations
